NetScientific's PDS investment signs deal for Covid-19 vaccine
(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.
Read more(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.
Read moreIN BRIEF: NetScientific's PDS Kicks Off Study For PDS0101 Cancer Drug
Read moreUK WINNERS & LOSERS SUMMARY: Taylor Wimpey Up On Strong Client Demand
Read moreNetScientific Reports Narrowed Annual Loss On Lower Costs
Read moreUK WINNERS & LOSERS SUMMARY: Foxtons Seeks Placing To Avoid Crisis
Read moreLONDON BRIEFING: Whiff Of Covid-19 Cure Sends Pharma Stocks Soaring
Read moreNetScientific Investee PDS Biotechnology To Develop Covid-19 Vaccine
Read moreNetScientific To Invest Further USD650,000 In PDS Biotechnology
Read moreNetScientific Mulls GBP500,000 Investment In PDS Biotech Fundraise
Read moreNetScientific CEO And CFO Ian Postlethwaite To Step Down In July
Read moreWoodford Transfers Series Of Holdings To New Manager Schroders
Read moreNetScientific Hires Former PwC Clarkson As Director, Wilson Steps Down
Read moreNetScientific's Glycotest Gets USD3 Million More From Fosun Pharma
Read moreNetScientific Appoints EMV Capital Managing Director As Non-Executive
Read moreNetScientific Shares Surge As Investee PDS Inks Merck & Co Pact
Read more